Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Ryohei YamamotoEnyu ImaiShoichi MaruyamaHitoshi YokoyamaHitoshi SugiyamaKosaku NittaTatsuo TsukamotoShunya UchidaAsami TakedaToshinobu SatoTakashi WadaHiroki HayashiYasuhiro AkaiMegumu FukunagaKazuhiko TsuruyaKosuke MasutaniTsuneo KontaTatsuya ShojiTakeyuki HiramatsuShunsuke GotoHirofumi TamaiSaori NishioArimasa ShirasakiKojiro NagaiKunihiro YamagataHajime HasegawaHideo YasudaShizunori IchidaTomohiko NaruseTomoya NishinoHiroshi SobajimaSatoshi TanakaToshiyuki AkahoriTakafumi ItoYoshio TeradaRitsuko KatafuchiShouichi FujimotoHirokazu OkadaEiji IshimuraJunichiro J KazamaKeiju HiromuraTetsushi MimuraSatoshi SuzukiYosuke SakaTadashi SofueYusuke SuzukiYugo ShibagakiKiyoki KitagawaKunio MorozumiYoshiro FujitaMakoto MizutaniTakashi ShigematsuNaoki KashiharaHiroshi SatoSeiichi MatsuoIchiei NaritaYoshitaka IsakaPublished in: Clinical and experimental nephrology (2020)
Patients with MCD and MN had a higher mortality, especially infection-related mortality, than ESKD. Nephrologists should pay more attention to infections in patients with primary nephrotic syndrome.